A Los Angeles woman identified by prosecutors as Jasveen Sangha has agreed to plead guilty to five federal charges for supplying the ketamine that led to Matthew Perry’s death, making her the fifth and final defendant in the case to accept a deal.
The Justice Department said Sangha, 42, will admit to maintaining a drug-involved premises, three counts of ketamine distribution, and distribution resulting in death or serious bodily injury. She has been in federal custody since August 2024 and is expected to formally enter the plea in the coming weeks. Statutory maximums outlined in the filing total decades in prison.
According to the plea agreement, Sangha and associate Erik Fleming sold 51 vials of ketamine in October 2023 that were routed to Perry’s live-in assistant, Kenneth Iwamasa, who injected the actor multiple times on the day he died.
The autopsy found Perry, 54, died from the acute effects of ketamine, which rendered him unconscious and contributed to drowning in his hot tub. Prosecutors say that after learning of Perry’s death, Sangha used the Signal app’s auto-delete feature and told Fleming to erase their messages. The agreement also ties her to an earlier fatal overdose in 2019 involving another buyer.
Four other defendants previously pleaded guilty for roles in the supply chain described by investigators, including the assistant and Fleming, as well as two physicians accused of illegally providing ketamine outside proper medical channels. Sentencing hearings for the earlier pleas are scheduled this fall, and Sangha’s plea would close the criminal liability phase that began with coordinated arrests last year.
Case filings describe Sangha’s North Hollywood apartment as a stash location stocked with ketamine and other drugs, reinforcing the government’s depiction of a pipeline that moved from a dealer network to a celebrity client in the days before the actor’s death.
